Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.32% | $3.93M | €413.15B | 48.58% | 76 Outperform | |
| Roche Holding AG | 2.13% | $2.53M | CHF272.24B | 45.48% | 73 Outperform | |
| AstraZeneca | 2.04% | $2.42M | £220.41B | 29.45% | 80 Outperform | |
| HSBC Holdings | 1.97% | $2.33M | £205.11B | 49.44% | 80 Outperform | |
| Novartis AG | 1.95% | $2.31M | CHF217.04B | 25.19% | 80 Outperform | |
| SAP SE | 1.77% | $2.10M | €241.78B | -14.21% | 66 Neutral | |
| Nestlé SA | 1.68% | $1.99M | CHF190.59B | 15.67% | 71 Outperform | |
| Siemens | 1.54% | $1.82M | €198.34B | 29.64% | 74 Outperform | |
| Shell (UK) | 1.42% | $1.68M | £150.06B | 0.57% | 73 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.35% | $1.60M | €324.15B | -0.39% | 78 Outperform |